In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetti to clarithromycin
about
Endocarditis due to rare and fastidious bacteriaQ feverIn vitro susceptibilities of 27 rickettsiae to 13 antimicrobialsIn vitro activities of telithromycin (HMR 3647) against Rickettsia rickettsii, Rickettsia conorii, Rickettsia africae, Rickettsia typhi, Rickettsia prowazekii, Coxiella burnetii, Bartonella henselae, Bartonella quintana, Bartonella bacilliformis, anNewer macrolides as empiric treatment for acute Q fever infection.Treatment of tick-borne diseases.In vitro susceptibilities of Bartonella henselae, B. quintana, B. elizabethae, Rickettsia rickettsii, R. conorii, R. akari, and R. prowazekii to macrolide antibiotics as determined by immunofluorescent-antibody analysis of infected Vero cell monolayRandomized Trial of Clarithromycin for Mediterranean Spotted FeverBacteriostatic and bactericidal activities of tigecycline against Coxiella burnetii and comparison with those of six other antibiotics.Treatment of Rickettsia spp. infections: a review.Nuclear magnetic resonance applied to antimicrobial drug susceptibility.In vitro susceptibility of Coxiella burnetii to linezolid in comparison with its susceptibilities to quinolones, doxycycline, and clarithromycin.In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin.Pharmacokinetics and pulmonary distribution of gamithromycin after intravenous administration in foals.[Spotted fever group rickettsial disease in Argentinean travelers]Clarithromycin versus azithromycin in the treatment of Mediterranean spotted fever in children: a randomized controlled trial.Doxycycline desensitization in chronic Q fever-A critical tool for the clinician.
P2860
Q24550691-5872E3E7-B1DC-4899-B093-1EB043BC3C39Q24550722-58F4DFBA-3EEE-4C1F-9106-65A86A3495ABQ33693813-38B23C75-E282-4CFE-A947-A1EF93C6128DQ33979566-DE603562-6275-46CD-B1D5-80D4352CAB14Q33983769-D66ADC05-E0CE-4E17-A0C1-18A7B835AF15Q34874402-0D3449FC-61C1-43A8-A118-4B989D6C8196Q35133675-0C0140BC-34CF-4D9F-BB3F-250968EF8E59Q36644887-6ED936D2-F94C-4AB3-8EF2-41D7AC3AA2A2Q37204133-EF1B25CB-1B7A-48F6-9E74-D9C3494DE750Q38068607-461535BB-6373-4296-911D-2F8DC1B1F968Q38093651-2F823793-59B6-46F0-9ABB-5687369CDF32Q39479010-E7C4A6D1-0224-4589-BA98-36A5C238B54DQ39559260-D2DBE4BB-85C3-4AA6-B736-78F8E693AD82Q40288754-B13538FC-07F9-4D8F-9A72-2EF9D127117BQ40589329-A4DE5B4C-DC27-4D13-9355-D0E773B67B6EQ40592078-855781E3-943F-44C3-8111-99AD265A4260Q54241635-15F0381E-2177-46EC-A17B-CBC42648B0D5
P2860
In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetti to clarithromycin
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
In vitro susceptibilities of s ...... lla burnetti to clarithromycin
@ast
In vitro susceptibilities of s ...... lla burnetti to clarithromycin
@en
type
label
In vitro susceptibilities of s ...... lla burnetti to clarithromycin
@ast
In vitro susceptibilities of s ...... lla burnetti to clarithromycin
@en
prefLabel
In vitro susceptibilities of s ...... lla burnetti to clarithromycin
@ast
In vitro susceptibilities of s ...... lla burnetti to clarithromycin
@en
P2860
P356
P1476
In vitro susceptibilities of s ...... lla burnetti to clarithromycin
@en
P2093
P2860
P304
P356
10.1128/AAC.37.12.2633
P407
P577
1993-12-01T00:00:00Z